Capital Meets Care: Q1 2025 Momentum Report from FemmeHealth Ventures Alliance

How we’re building the capital stack for women’s health—insights, signals, and what’s next

FemmeHealth Ventures Alliance (formerly Notes to Selfe) was launched with one mission: to close the gender health gap through smart, strategic capital, and in just 90 days, our momentum has been undeniable.

---

If this email was forwarded to you, you have awesome friends. Click below to join. Don’t forget, you can always explore our archives to catch up on any past stories.

---

Before We Dive In: What Mattered This Week

Signal Not Noise: How We Measure Credibility Now

The real signal this week wasn’t another funding headline but how we measure credibility. From regulatory risk to clinical validation, a new bar is emerging.

Read the full post here [Signal Not Noise: What Mattered in Women’s Health Investing (Apr 14 - 19]

---

Capital Meets Care: Q1 2025 Momentum Report from FemmeHealth Ventures Alliance

How we are building the capital stack for women’s health—insights, signals, and what’s next.

Dear Investors, Founders, and Changemakers shaping the future of women’s health,

In just 90 days, FemmeHealth Ventures Alliance (formerly Notes to Selfe) has become a go-to source for high-conviction insights, founder signals, and deal-flow visibility at the intersection of capital and care.

We launched with a singular purpose: to close the gender health gap by transforming how and by whom capital is allocated. Here is what we have built in Q1 2025:

---

📈 Q1 Highlights — The Momentum Is Real

• Subscribers: Grew from 142 to 2,745 (+1,800%)

• Content: 20+ data-backed articles, 2 podcast episodes.

• Most-Read Posts:

  • “Women’s Health is Mispriced And That’s a Multi-Billion Dollar Problem” (1.75k views)

  • “The Autoimmune Gender Gap: 10 Private Companies to Watch” (1.41k views)

• Community: +200 followers each on Instagram and LinkedIn.

• Podcast: Featured innovations in drug delivery and postpartum recovery.

• Rebrand: From Notes to Selfe to FemmeHealth Ventures Alliance, a name that signals where we are headed, not just where we began.

  ---

👩‍🔬 Founder Signal: Lara Zibners, Calla Lily Clinical Care

We first featured Lara for her novel approach to progesterone-based drug delivery. Weeks later, she secured $1M in funding to advance the tech.

This is why we exist: to elevate overlooked innovations solving billion-dollar blind spots.

🔎 What We Learned — And What It Means for You

• Segment-Specific Messaging Works: Investors want repeatable signals and sector maps. Founders want visibility and credible touchpoints. We are now building tailored journeys for both.

• Narrative Drives Action: Numbers matter, but story converts. Our top posts combined clinical data with market opportunity and got shared across funder circles.

• Rebrand → Clarity → Traction: The FemmeHealth name sharpened our positioning and increased referrals, especially among allocators and angels.

---

🔮 Coming in Q2 — Building the Next Layer of Infrastructure

Here’s what we are building:

• Investor Readiness Masterclass (Beta cohort) launches September; pre-sale and prep begins soon.

• Podcast Guests: Skincare, microbiome, and diagnostics founders already confirmed.

• Founder Spotlights: Monthly features across Substack and Instagram.

• Resource Guide: Global Angel Club Directory (free + premium access tiers)

• Special Series (Coming Soon): A new editorial collaboration to help mainstream the women’s health investing thesis. More details to follow.

---

---

🙋‍♀️ How You Can Support

• Share this newsletter with allocators, GPs, or angels exploring women’s health.

• Nominate a founder or investor for our FemmeHealth Founder Series.

• Sponsor or partner with us to reach our fast-growing investor and founder base.

• Donate to fuel independent research and coverage.

• Follow us on Instagram for behind-the-scenes intel and founder quick takes.

We are not just reporting on the space. We are building the connective tissue for capital, credibility, and scale. Thanks for being here from the start.

Founder, FemmeHealth Ventures Alliance
#BillionDollarBlindSpot | #FemmeHealth

---

Disclaimer & Disclosure

This content is for informational and educational purposes only. It does not constitute financial, investment, legal, or medical advice, or an offer to buy or sell any securities. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making investment decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.